LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

HIV-1 drug resistance mutation analyses of Cameroon derived Integrase sequences.

Photo by tamba from unsplash

HIV-1 Integrase (IN) is a primary target for combination antiretroviral therapy (cART). Only a limited number of studies report on the emergence of resistance-associated mutations (RAMs) in Cameroon. We observed… Click to show full abstract

HIV-1 Integrase (IN) is a primary target for combination antiretroviral therapy (cART). Only a limited number of studies report on the emergence of resistance-associated mutations (RAMs) in Cameroon. We observed that (1.4%) of sequence from treatment naïve patients had Integrase strand transfer inhibitor (INSTI) RAMs. These mutations confer resistance to raltegravir (RAL) and elvitegravir (EVG). We also observed that 10.1% of the sequences have INSTI accessory RAMs. HIV-1 CRF02_AG was the predominant subtype (44.7.%) in this study analyses. The occurrence of INSTI RAMs among the sequences at baseline needs to be monitored carefully.

Keywords: hiv drug; cameroon; resistance mutation; resistance; drug resistance; mutation analyses

Journal Title: AIDS research and human retroviruses
Year Published: 2020

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.